TrialThe Journal of infectious diseases2025

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.